John R. Charpie

John R. Charpie

Auto-generated profile, based on publicly available information

John R. Charpie

Division of Pediatric Cardiology, Department of Pediatrics, University of Michigan Medical School, Ann Arbor, USA

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2000 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
JCJohn R. Charpie
John R. Charpie
MDMary K. Dekeon
Mary K. Dekeon
CGCaren S. Goldberg
Caren S. Goldberg
RMRalph S. Mosca
Ralph S. Mosca
EBEdward L. Bove
Edward L. Bove
TKThomas J. Kulik
Thomas J. Kulik

20 February 2011 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
JGJessica R. Golbus
Jessica R. Golbus
BWBrandon M. Wojcik
Brandon M. Wojcik
JCJohn R. Charpie
John R. Charpie
JHJennifer C. Hirsch
Jennifer C. Hirsch

1 January 2019 in Seminars in Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
YPYun-Wen Peng
Yun-Wen Peng
AMAzmath Mohammed
Azmath Mohammed
KDKristopher B. Deatrick
Kristopher B. Deatrick
TMTerry Major
Terry Major
DCDorothy Cheng
Dorothy Cheng
JCJohn R. Charpie
John R. Charpie

1 March 2008 in Congenital Heart Disease
Verified
Journal Article
Closed access
PDF file
GAGinnie L. Abarbanell
Ginnie L. Abarbanell
CGCaren S. Goldberg
Caren S. Goldberg
EDEric J. Devaney
Eric J. Devaney
RORichard G. Ohye
Richard G. Ohye
EBEdward L. Bove
Edward L. Bove
JCJohn R. Charpie
John R. Charpie
To review early surgical outcomes in a contemporary series of adults with congenital heart disease (CHD) undergoing cardiac operations at the University of Michigan, and to investigate possible preoperative and intraoperative risk factors for morbidity and mortality. A retrospective medical record review was performed for all patients > or =18 years of age who underwent open heart operations by a pediatric cardiothoracic surgeon at the University of Michigan Congenital Heart Center between January 1, 1998 and December 31, 2004. Records from a cohort of pediatric patients ages 1-17 years were matched to a subset of the adult patients by surgical procedure and date of operation. In total, 243 cardiac surgical operations were performed in 234 adult patients with CHD. Overall mortality was 4.7% (11/234). The incidence of major postoperative complications was 10% (23/234) with a 19% (45/23) minor complication rate. The most common postoperative complication was atrial arrhythmias in 10.8% (25/234). The presence of preoperative lung or liver disease, prolonged cardiopulmonary bypass and aortic cross clamp times, and postoperative elevated inotropic score and serum lactates were significant predictors of mortality in adults. There was no difference between the adult and pediatric cohorts in terms of mortality and morbidity. The postoperative course in adults following surgery for CHD is generally uncomplicated and early survival should be expected. Certain risk factors for increased mortality in this patient population may include preoperative presence of chronic lung or liver dysfunction, prolonged cardiopulmonary bypass and aortic cross-clamp times, and postoperative elevated inotropic score and serum lactate levels.

3 February 2016 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
NSNathaniel Sznycer-Taub
Nathaniel Sznycer-Taub
SMStewart Mackie
Stewart Mackie
YPYun-Wen Peng
Yun-Wen Peng
JDJanet Donohue
Janet Donohue
SYSunkyung Yu
Sunkyung Yu
JCJohn Charpie
John Charpie

10 June 2020 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
YPYun-Wen Peng
Yun-Wen Peng
TMTerry Major
Terry Major
AMAzmath Mohammed
Azmath Mohammed
KDKristopher B. Deatrick
Kristopher B. Deatrick
JCJohn R. Charpie
John R. Charpie
Background: In a rabbit model of cardiopulmonary bypass (CPB) and cardioplegic arrest, we previously showed that hyperoxic myocardial reperfusion was associated with increased left ventricular (LV) systolic dysfunction and myocardial injury compared with normoxic reperfusion. The aim of this study was to evaluate in our experimental model the impact of post-CPB reperfusion conditions on other organs potentially vulnerable to ischemic injury such as the brain and kidney. Methods: After 60 min of CPB, aortic cross-clamp, and cold cardioplegic arrest, rabbits were reperfused under hyperoxic or normoxic conditions for 120 min. Left ventricular systolic contractility (LV + dP/dt) and diastolic relaxation (LV –dP/dt) were continuously recorded, and end-organ injury was assessed by measuring circulating biomarkers specific for kidney (cystatin C and creatinine) and brain injury [S100B and neuron specific enolase (NSE)]. At completion of the protocol, kidney and brain tissues were harvested for measuring oxidant stress (OS), inflammation and apoptosis. Results: Following aortic cross-clamp removal, rabbits exposed to normoxic reperfusion demonstrated preserved LV systolic and diastolic function compared with hyperoxic reperfusion (LV + dP/dt: 70 ± 14% of pre-CPB vs. 36 ± 21%, p = 0.018; LV -dP/dt: 72 ± 36% of pre-CPB vs. 33 ± 20%, p = 0.023). Similarly, CPB increased plasma creatinine, S100B and NSE that were significantly attenuated by normoxic reperfusion compared with hyperoxic reperfusion (creatinine: 4.0 ± 0.5 vs. 7.1 ± 0.8 mg/dL, p = 0.004; S100B: 4.0 ± 0.8 vs. 6.7 ± 1.0 ng/mL, p = 0.047; NSE: 57.7 ± 6.8 vs. 101.3 ± 16.1 pg/mL, p = 0.040). Furthermore, both kidney and brain tissues showed increased mRNA expression and activation of pathways for OS, inflammation, and apoptosis, that were reduced under normoxic compared with hyperoxic conditions. Conclusions: Normoxic reperfusion ameliorates cardiac, renal and neural injury compared with hyperoxic reperfusion in an in vivo animal model of CPB and cardioplegic arrest. This protective effect of normoxic reperfusion may be due to a reduction in signaling pathways for OS, inflammation, and apoptosis.